Clinical Trials Sponsored by Tianjin Chest Hospital

Total 1707 results

Tianjin Chest Hospital

Recruiting

Effect of Evolocumab Added to Moderate-Intensity Statin Therapy on LDL-C Lowering and Cardiovascular Adverse Events in Patients With Acute Coronary Syndrome (EMSIACS)

Acute Coronary Syndrome | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor

China
Tianjin Chest Hospital

Unknown

Virtual Histology Intravascular Ultrasound to Evaluate Prognostic Risks of Saphenous Vein Graft Disease Before Percutaneous Coronary Intervention.

Percutaneous Coronary Intervention | Saphenous Vein Graft Disease | Major Adverse Cardiovascular Events | Virtual Histology Intravascular Ultrasound

China
Tianjin Chest Hospital

Recruiting

Pembrolizumab as First-line Treatment for Advanced NSCLC Complicated With COPD

NSCLC With COPD

China
Tianjin Chest Hospital

Recruiting

CCTA Improves Clinical Management of Stable Chest Pain (CICM-SCP)

Coronary Artery Disease | Major Adverse Cardiovascular Events | Coronary Computed Tomography Angiography | Revascularization | Stable Chest Pain | Optimal Medical Therapy | Invasive Coronary Angiography

China
Tianjin Chest Hospital

Recruiting

Intravascular Ultrasound-derived Assessment of Hemodynamically Negative Lesions in NSTEACS Patients (IMPACT-NSTEACS)

Non-ST-segment Acute Coronary Syndrome

China
Tianjin Chest Hospital

Recruiting

Optimal Evaluation to Reduce Imaging Testing (OPERATE)

Chronic Coronary Syndrome

China
Tianjin Chest Hospital

Recruiting

Tianjin Inpatient Acute Myocardial Infarction Registry (TAMI)

Myocardial Infarction, Acute

China
Yale University
Tianjin Chest Hospital

Completed

Multisite Tissue Oxygenation Guided Perioperative Care in Cardiac Surgery (BOTTOMLINECS)

Brain Ischemia Hypoxia | Muscle; Ischemic | Muscle Hypoxia

China
Tianjin Medical University Cancer Institute and...
Tianjin Chest Hospital

Recruiting

Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma

Squamous Cell Carcinoma | Lung Neoplasm | Exosomes

China
Tianjin Medical University Cancer Institute and...
Tianjin Medical University General Hospital; Tianjin Chest Hospital

Completed

Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium

Delirium | Analgesia | NSCLC | Immunotherapy

China
Tianjin Chest Hospital
LinkDoc Technology (Beijing) Co. Ltd.

Completed

A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Beijing Tiantan Hospital
Tianjin Medical University General Hospital

Recruiting

Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination (STAND)

Nervous System Diseases | Immune System Diseases | Autoimmune Diseases of the Nervous System | Autoimmune Diseases | Diagnostic Self Evaluation | NMO Spectrum Disorder | NMDA-R Encephalitis

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS) (BLESS)

Esophageal Cancer

China
Shanghai Chest Hospital

Recruiting

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

Carcinoma | Non-small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Association of Psychological Distress in Patients With Lung Cancer (Life-Score)

Lung Neoplasms | Psychological Distress | IMMUNOTHERAPY | Lifestyle, Healthy | Targeted Molecular Therapy | Prognosis Factors

China
Beijing Chest Hospital

Not yet recruiting

Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

Malnutrition | Lung Cancer | Amino Acid Deficiency
Shanghai Chest Hospital

Not yet recruiting

Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT）

Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Recruiting

Feasibility of Thin Cp-EBUS Scope BF-UC290F for the Diagnosis of PPLs

Peripheral Pulmonary Nodules

China
Shanghai Chest Hospital

Recruiting

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Non-small Cell Lung Cancer | Minimal Residual Disease | Immunotherapy | Anti-angiogenesis

China
Shanghai Chest Hospital

Not yet recruiting

Catheter Ablation and Surgical Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.

Persistent Atrial Fibrillation
Shanghai Chest Hospital

Not yet recruiting

A Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC. (CAMFA-L)

NSCLC

China
Shanghai Chest Hospital

Not yet recruiting

Almonertinib Versus Osimertinib in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases (ATTACK)

NSCLC
Shanghai Chest Hospital

Not yet recruiting

To Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 Fusion

NRG1-fused Non-small Cell Lung Cancer

China
Beijing Chest Hospital

Recruiting

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Tuberculosis

China
Shanghai Chest Hospital

Recruiting

Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

Non-small-cell Lung Cancer

China
Shanghai Chest Hospital

Completed

Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients

Non Small Cell Lung Cancer

China
Shanghai Chest Hospital

Completed

Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation With Right Atrial Enlargement

Persistent Atrial Fibrillation | Right Atrial Enlargement

China
Shanghai Chest Hospital

Unknown

Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer

SCLC | Anlotinib

China
Shanghai Chest Hospital

Unknown

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Recurrence | Metastasis | Esophageal Squamous Cell Carcinoma | Apatinib

China
Shanghai Chest Hospital

Completed

Analysis of Re-biopsy Specimens in Advanced NSCLC With Acquired Resistance of EGFR-TKI Targeted Therapy

Lung Cancer

China
Shanghai Chest Hospital

Unknown

To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation

Lung Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Unknown

Combination Therapy of Sintilimab and Anlotinib as a First-line Treatment in Advanced NSCLC (SUNRISE)

Carcinoma | Non-small Cell Lung Cancer
Shanghai Chest Hospital

Completed

UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLs

Lung Cancer

China
Beijing Chest Hospital

Unknown

Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Shanghai Chest Hospital

Unknown

Intraoperative Ultrasonographic Localization of Pulmonary Nodules in VATS

Ultrasonography
Shanghai Chest Hospital

Unknown

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC (HCFCCUSN)

Unresectable Stage III Non-small-cell Lung Cancer

China
Shanghai Chest Hospital

Unknown

ENB Guided RFA for Early-stage Peripheral Lung Cancer

Lung Cancer

China
Shanghai Chest Hospital

Unknown

SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations

NSCLC | SBRT | GM-CSF

China
Shanghai Chest Hospital

Unknown

Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

NSCLC

China
Shanghai Chest Hospital

Unknown

Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer

Lung Cancer

China
Shanghai Chest Hospital

Unknown

Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer

Esophageal Cancer | Chemoradiation | Surgery

China
Shanghai Chest Hospital

Unknown

Percutaneous Cryoablation Peripheral Lung Cancer (PCPLC)

Lung Cancer
Shanghai Chest Hospital

Unknown

Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) (EGFR)

Non-Small Cell Lung Cancer | Brain Metastases | EGFR Gene Mutation

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) (neoR-TORCH)

Stage II-III Non-small Cell Lung Cancer
Shanghai Chest Hospital

Recruiting

Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation

Anastomotic Leak | Esophageal Neoplasm | Anastomotic Stenosis | Recurrent Laryngeal Nerve Injuries | Endoscopic Evaluation

China
Shanghai Chest Hospital

Not yet recruiting

Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC: a Single Arm, Prospective Phase 2 Clinical Trial

Esophageal Squamous Cell Carcinoma

China
Shanghai Chest Hospital

Not yet recruiting

RAE Versus MIE in Patients With Esophageal Cancer After Neoadjuvant Therapy

Surgical Procedure, Unspecified

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of SCLC

Small Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Limited Stage | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer, Combined Type

China

Clinical Trials Sponsored by Tianjin Chest Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations